A detailed history of Midwest Financial Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Midwest Financial Group LLC holds 1,069 shares of ABBV stock, worth $215,595. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,069
Holding current value
$215,595
% of portfolio
0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$163.84 - $199.33 $175,144 - $213,083
1,069 New
1,069 $211 Million
Q4 2023

Jan 25, 2024

SELL
$137.6 - $154.97 $154,387 - $173,876
-1,122 Reduced 15.2%
6,258 $970 Million
Q3 2023

Oct 17, 2023

BUY
$133.59 - $154.65 $3,072 - $3,556
23 Added 0.31%
7,380 $1.1 Billion
Q2 2023

Jul 27, 2023

SELL
$132.51 - $164.9 $6,625 - $8,245
-50 Reduced 0.68%
7,357 $991 Million
Q1 2023

Apr 20, 2023

BUY
$144.61 - $166.54 $1.07 Million - $1.23 Million
7,407 New
7,407 $1.18 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $357B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Midwest Financial Group LLC Portfolio

Follow Midwest Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Midwest Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Midwest Financial Group LLC with notifications on news.